Year |
Citation |
Score |
2023 |
Adegbesan KA, Tomassoni Ardori F, Yanpallewar S, Bradley SP, Chudasama Y, Vera E, Briceno N, King AL, Tessarollo L, Gilbert MR, Guedes VA, Smart DK, Armstrong TS, Shuboni-Mulligan DD. The sex-dependent impact of PER2 polymorphism on sleep and activity in a novel mouse model of cranial-irradiation-induced hypersomnolence. Neuro-Oncology Advances. 5: vdad108. PMID 37781088 DOI: 10.1093/noajnl/vdad108 |
0.674 |
|
2022 |
King AL, Shuboni-Mulligan DD, Vera E, Crandon S, Acquaye AA, Boris L, Burton E, Choi A, Christ A, Grajkowska E, Jammula V, Leeper HE, Lollo N, Penas-Prado M, Reyes J, et al. Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients. Neuro-Oncology Practice. 9: 526-535. PMID 36388423 DOI: 10.1093/nop/npac049 |
0.683 |
|
2022 |
Ruiz-Rodado V, Dowdy T, Lita A, Kramp T, Zhang M, Shuboni-Mulligan D, Herold-Mende C, Armstrong TS, Gilbert MR, Camphausen K, Larion M. Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model. Frontiers in Oncology. 12: 979537. PMID 36353533 DOI: 10.3389/fonc.2022.979537 |
0.468 |
|
2022 |
Shuboni-Mulligan DD, Young D, De La Cruz Minyety J, Briceno N, Celiku O, King AL, Munasinghe J, Wang H, Adegbesan KA, Gilbert MR, Smart DK, Armstrong TS. Histological analysis of sleep and circadian brain circuitry in cranial radiation-induced hypersomnolence (C-RIH) mouse model. Scientific Reports. 12: 11131. PMID 35778467 DOI: 10.1038/s41598-022-15074-0 |
0.69 |
|
2021 |
De La Cruz Minyety J, Shuboni-Mulligan DD, Briceno N, Young D, Gilbert MR, Celiku O, Armstrong TS. Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient Survival. Cancers. 13. PMID 34199348 DOI: 10.3390/cancers13112756 |
0.56 |
|
2021 |
Shuboni-Mulligan DD, Young DL, De La Cruz Minyety J, Vera E, Munasinghe J, Gall AJ, Gilbert MR, Armstrong TS, Smart DK. Impact of age on the circadian visual system and the sleep-wake cycle in mus musculus. Npj Aging and Mechanisms of Disease. 7: 10. PMID 33947857 DOI: 10.1038/s41514-021-00063-w |
0.501 |
|
2020 |
Chakravarty S, Hix JML, Wiewiora KA, Volk MC, Kenyon E, Shuboni-Mulligan DD, Blanco-Fernandez B, Kiupel M, Thomas J, Sempere LF, Shapiro EM. Tantalum oxide nanoparticles as versatile contrast agents for X-ray computed tomography. Nanoscale. PMID 32211669 DOI: 10.1039/D0Nr01234C |
0.651 |
|
2019 |
Shuboni-Mulligan DD, Breton G, Smart D, Gilbert M, Armstrong TS. Radiation chronotherapy-clinical impact of treatment time-of-day: a systematic review. Journal of Neuro-Oncology. PMID 31729636 DOI: 10.1007/S11060-019-03332-7 |
0.477 |
|
2019 |
Shuboni-Mulligan DD, Cavanaugh BL, Tonson A, Shapiro EM, Gall AJ. Functional and anatomical variations in retinorecipient brain areas in and : implications for the circadian and masking systems. Chronobiology International. 1-18. PMID 31441335 DOI: 10.1080/07420528.2019.1651325 |
0.564 |
|
2019 |
Shuboni-Mulligan DD, Chakravarty S, Mallett CL, Wolf AM, Dmitriev PM, Forton SM, Shapiro EM. In vivo serial MRI of age-dependent neural progenitor cell migration in the rat brain. Neuroimage. 199: 153-159. PMID 31152841 DOI: 10.1016/J.Neuroimage.2019.05.073 |
0.676 |
|
2019 |
Mir FF, Tomaszewski RP, Shuboni-Mulligan DD, Mallett CL, Hix JML, Ether ND, Shapiro EM. Chimeric mouse model for MRI contrast agent evaluation. Magnetic Resonance in Medicine. PMID 30874333 DOI: 10.1002/mrm.27730 |
0.556 |
|
2019 |
Young D, Dee Smart D, King A, Gilbert M, Armstrong T, Shuboni-Mulligan D. RDNA-13. DOSE RESPONSE CURVE FOR RADIATION-INDUCED HYPERSOMNOLENCE (RIH) IN A MOUSE MODEL OF CRANIAL RADIATION: BEHAVIORAL ANALYSIS OF SLEEP AND ACTIVITY Neuro-Oncology. 21: vi209-vi209. DOI: 10.1093/Neuonc/Noz175.872 |
0.693 |
|
2019 |
Shuboni-Mulligan D, Dahut M, Young D, Gilbert M, Armstrong T. RDNA-04. CIRCADIAN RHYTHMS AND RADIATION CHRONOTHERAPY IN GLIOBLASTOMA CELL LINES AND CENTRAL NERVOUS SYSTEM CELL CONTROLS Neuro-Oncology. 21: vi207-vi207. DOI: 10.1093/Neuonc/Noz175.864 |
0.557 |
|
2019 |
King A, Shuboni-Mulligan D, Vera E, Crandon S, Aboud O, Antony R, Boris L, Bryla C, Burton E, Cordova C, Gartland C, Grajkowska E, Penas-Prado M, Reyes J, Leggiero N, et al. QOLP-36. THE IMPORTANCE OF SLEEP DISTURBANCE IN PRIMARY BRAIN TUMOR (PBT) PATIENTS: CLINICAL CHARACTERISTICS & CO-OCCURRENCE WITH TUMOR-RELATED & PSYCHOLOGICAL SYMPTOMS Neuro-Oncology. 21: vi205-vi206. DOI: 10.1093/Neuonc/Noz175.856 |
0.684 |
|
2018 |
Mallett CL, Shuboni-Mulligan DD, Shapiro EM. Tracking Neural Progenitor Cell Migration in the Rodent Brain Using Magnetic Resonance Imaging. Frontiers in Neuroscience. 12: 995. PMID 30686969 DOI: 10.3389/Fnins.2018.00995 |
0.585 |
|
2018 |
Shuboni-Mulligan DD, Parys M, Blanco-Fernandez B, Mallett CL, Schnegelberger R, Takada M, Chakravarty S, Hagenbuch B, Shapiro EM. Dynamic Contrast-Enhanced Magnetic Resonance Imaging of OATP Dysfunction in Diabetes. Diabetes. PMID 30487262 DOI: 10.2337/Db18-0525 |
0.653 |
|
2018 |
Figiel C, Shuboni-Mulligan D, Armstrong T, Smart D. RDNA-13. VALIDATION OF BEHAVIORAL ANALYSIS ACROSS AGE IN A MOUSE MODEL FOR FUTURE INVESTIGATION OF RADIATION-INDUCED HYPERSOMNOLENCE (RIH) IN PRIMARY BRAIN TUMOR (PBT) PATIENTS Neuro-Oncology. 20: vi224-vi224. DOI: 10.1093/Neuonc/Noy148.928 |
0.544 |
|
2018 |
Shuboni-Mulligan D, Blanco-Fernandez B, Chakravarty S, Shapiro E. ANGI-12. MRI-BASED CELL TRACKING WITH INDIVIDUAL CELL SENSITIVITY FOR MEASURING CANCER CELL INVASION Neuro-Oncology. 20: vi30-vi30. DOI: 10.1093/Neuonc/Noy148.113 |
0.666 |
|
2017 |
Roach DR, Garrett WM, Welch G, Shuboni-Mulligan DD, Caperna TJ, Talbot NC, Shapiro EM. Correction: Magnetic Cell Labeling of Primary and Stem Cell-Derived Pig Hepatocytes for MRI-Based Cell Tracking of Hepatocyte Transplantation. Plos One. 12: e0185524. PMID 28934350 DOI: 10.1371/Journal.Pone.0185524 |
0.555 |
|
2016 |
Chakravarty S, Unold J, Shuboni-Mulligan DD, Blanco-Fernandez B, Shapiro EM. Surface engineering of bismuth nanocrystals to counter dissolution. Nanoscale. 8: 13217-22. PMID 27356280 DOI: 10.1039/C6Nr02171A |
0.638 |
|
Show low-probability matches. |